1-161040573-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_007122.5(USF1):c.714+3C>T variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000484 in 1,611,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000051 ( 0 hom. )
Consequence
USF1
NM_007122.5 splice_donor_region, intron
NM_007122.5 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.02128
2
Clinical Significance
Conservation
PhyloP100: 2.77
Genes affected
USF1 (HGNC:12593): (upstream transcription factor 1) This gene encodes a member of the basic helix-loop-helix leucine zipper family, and can function as a cellular transcription factor. The encoded protein can activate transcription through pyrimidine-rich initiator (Inr) elements and E-box motifs. This gene has been linked to familial combined hyperlipidemia (FCHL). Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been defined on chromosome 21. [provided by RefSeq, Feb 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BS2
High AC in GnomAdExome4 at 74 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USF1 | NM_007122.5 | c.714+3C>T | splice_donor_region_variant, intron_variant | ENST00000368021.7 | NP_009053.1 | |||
USF1 | NM_001276373.2 | c.714+3C>T | splice_donor_region_variant, intron_variant | NP_001263302.1 | ||||
USF1 | NM_207005.3 | c.537+3C>T | splice_donor_region_variant, intron_variant | NP_996888.1 | ||||
USF1 | XM_047429959.1 | c.537+3C>T | splice_donor_region_variant, intron_variant | XP_047285915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USF1 | ENST00000368021.7 | c.714+3C>T | splice_donor_region_variant, intron_variant | 1 | NM_007122.5 | ENSP00000357000 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151970Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
151970
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000132 AC: 33AN: 249352Hom.: 0 AF XY: 0.000178 AC XY: 24AN XY: 134790
GnomAD3 exomes
AF:
AC:
33
AN:
249352
Hom.:
AF XY:
AC XY:
24
AN XY:
134790
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000507 AC: 74AN: 1459720Hom.: 0 Cov.: 32 AF XY: 0.0000675 AC XY: 49AN XY: 726196
GnomAD4 exome
AF:
AC:
74
AN:
1459720
Hom.:
Cov.:
32
AF XY:
AC XY:
49
AN XY:
726196
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151970Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74210
GnomAD4 genome
AF:
AC:
4
AN:
151970
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
74210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 26, 2023 | Does not currently meet published gene-disease clinical validity criteria Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at